Eli Lilly and Company is proud to sponsor the World Migraine Summit. To learn more about our approved product, click here.
PP-GZ-US-0668
Archives: Sponsors
Allergan
Chronic Migraine is different. It’s a distinct condition of 15 or more headache days a month, each lasting 4 hours or more per headache day.
Chronic Migraine can be so debilitating that experts recommend treating Chronic Migraine with a preventive medication. Preventive medication is used before a migraine or headache even starts. BOTOX® prevents on average 8 to 9 headache days and migraine/probable migraine days a month (vs 6 to 7 for placebo).
BOTOX® is for adults with Chronic Migraine, 15 or more headache days a month, each lasting 4 hours or more. It is not approved for 14 or fewer headache days a month.
Did you know?
• BOTOX® is the #1 prescribed branded Chronic Migraine treatment*
• 2 million BOTOX® treatments have been given to over 500,000 people with Chronic Migraine since FDA approval in 2010.
• BOTOX® treatment is recommended every 12 weeks. Appointments last about 15 minutes.
*Data on File
All trademarks are the property of their respective owners. © 2019 Allergan. All rights reserved. BCM122289 03/19
Amgen / Novartis
#SpeakYourMigraine is a global initiative by Amgen and Novartis to raise awareness of the total impact of migraine. The campaign aims to drive more understanding of the larger impacts this disease has at work, at home, among friends… and everywhere (find out more: www.speakyourmigraine.com).
Teva
For U.S. Audiences Only
With less migraine, find your moments.
Why AJOVY®?
AJOVY is a preventive treatment option that has been shown to reduce the average number of days people experience migraine.
It’s the only FDA-approved anti-calcitonin gene-related peptide (CGRP) that has the flexibility of quarterly and monthly dosing options.* Talk to your doctor to see if AJOVY may be right for you and if you can start AJOVY without stopping your current migraine medications.
Are you currently taking AJOVY® and are interested in sharing your story? Teva Pharmaceuticals would like to hear from you. Email [email protected] for details.
*Quarterly dosing is three 225 mg subcutaneous (under the skin) injections every 3 months. Monthly dosing is one 225 mg subcutaneous injection each month.
Approved Use
AJOVY® is a prescription medicine used to prevent migraine in adults.
Important Safety Information
Do not use AJOVY if you are allergic to AJOVY or any of the ingredients in AJOVY.
AJOVY may cause allergic reactions, including itching, rash, and hives that can happen within hours and up to 1 month after receiving AJOVY. Call your healthcare provider or get emergency medical help right away if you have any symptoms of an allergic reaction: swelling of your face, mouth, tongue, throat, or if you have trouble breathing. Talk to your doctor about stopping AJOVY if you have an allergic reaction.
Tell your healthcare provider about all the medicines you take, and if you are pregnant, planning to become pregnant or are breastfeeding.
Common side effects of AJOVY include injection site reactions.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of AJOVY. For more information, ask your healthcare provider or pharmacist.
Call your doctor for medical advice about side effects. You are encouraged to report side effects to the FDA at 1-800-FDA-1088.
Please click here for full prescribing information for AJOVY® (fremanezumab-vfrm) injection. FRE-41645 March 2019
